Any updates @TorontoPearson or @CanBorder on the issue? We’ve been on our plane for 1.5hours with no update on when we will get off or how long through customs. Would be helpful to have an estimate to work with.
16
Niloufar Keshmiri retweeted
An important message from John Green re: Johnson & Johnson's pursuit of the secondary patent of bedaquiline, which would result in an estimated 6 million people not being able to afford this treatment.
@JNJNews @JNJGlobalHealth we must put people over profits.
An open letter to @JNJNews. Stop pursuing the secondary patent of bedaquiline. YOU KNOW that millions of people will be unable to access lifesaving treatment for multidrug-resistant tuberculosis if you extend the patent. YOU KNOW it violates your credo. youtube.com/watch?v=tMhgw5SW…
J&J, if you believe in living your values, “our first responsibility is to patients” then you’ll admit that “enabling [DFC] to invite potential generic suppliers” is not the same as ceasing pursuit of your secondary patent. Open access, save lives #PatientsNotPatents
It is false to suggest—as some recently have—that our patents are being used to prevent access to SIRTURO® (bedaquiline), our medicine for MDR-TB.
In fact, we have already entered into a collaboration with the Stop TB Partnership’s Global Drug Facility (“GDF”)—the largest procurer of TB medicines—which enables them to invite potential generic suppliers and purchase generic versions of SIRTURO® 100mg. On April 5, during a World Health Organization meeting, the GDF shared its intent to launch a tender for generic versions of SIRTURO® 100mg in the third quarter of 2023: social.jnj.com/3XSgjRZ
In addition, we have shipped more than 660,000 courses of SIRTURO® to 159 countries since launch. Our patents made this possible, enabling us to assist countries to scale-up their use of our medicine responsibly and sustainably and invest in multiple, critical, anti-TB efforts. For instance, in the face of rising drug resistance, we support stewardship efforts that ensure MDR-TB patients can benefit from our medicine today and in the future.
Unfortunately, the most significant barrier to treatment access for patients today is the fact that millions of patients with TB go undiagnosed every year. This is a challenge that we have invested significant resources to overcome and must all get behind if we are to achieve the global goal of ending TB.
1
3
233
In case you are seeing this, are confused, wanna learn more or join the pressure campaign. Barely Contained Rage: An Open Letter to Johnson & Johnson youtu.be/tMhgw5SW0h4 via @YouTube
1
52
Niloufar Keshmiri retweeted
Like many intentionally confusing corporate crisis response messages, this says a bunch of things that are true but don’t mean what you think, like for example:
“On April 5, during a World Health Organization meeting, the GDF shared its intent to launch a tender for generic versions of SIRTURO® 100mg in the third quarter of 2023”
This sounds like it says “everybody can have generic bedaquiline!!” But actually they *had to allow* the production of a generic because some countries had the power and systems in place to reject their attempt to extend their patent. The generic will not be available in countries where the patent extension wasn’t rejected, just like John said in his video.
Unless that’s not the case @JNJNews!!
If you’re telling us that you will allow the sale of generics anywhere in the developing world then we will happily send thank you baskets to your entire c-suite! Please let us know! Maybe we got it wrong and you only did the arduous work of extending the patent in a bunch of developing countries for funsies!
It is false to suggest—as some recently have—that our patents are being used to prevent access to SIRTURO® (bedaquiline), our medicine for MDR-TB.
In fact, we have already entered into a collaboration with the Stop TB Partnership’s Global Drug Facility (“GDF”)—the largest procurer of TB medicines—which enables them to invite potential generic suppliers and purchase generic versions of SIRTURO® 100mg. On April 5, during a World Health Organization meeting, the GDF shared its intent to launch a tender for generic versions of SIRTURO® 100mg in the third quarter of 2023: social.jnj.com/3XSgjRZ
In addition, we have shipped more than 660,000 courses of SIRTURO® to 159 countries since launch. Our patents made this possible, enabling us to assist countries to scale-up their use of our medicine responsibly and sustainably and invest in multiple, critical, anti-TB efforts. For instance, in the face of rising drug resistance, we support stewardship efforts that ensure MDR-TB patients can benefit from our medicine today and in the future.
Unfortunately, the most significant barrier to treatment access for patients today is the fact that millions of patients with TB go undiagnosed every year. This is a challenge that we have invested significant resources to overcome and must all get behind if we are to achieve the global goal of ending TB.
Niloufar Keshmiri retweeted
ABC News has projected that Jon Ossoff has won his US Senate race in Georgia and therefore that Democrats will gain control of the US Senate.
Niloufar Keshmiri retweeted
Congratulations to my friends, @JoeBiden and @KamalaHarris — our next President and Vice President of the United States.
Niloufar Keshmiri retweeted
Today is a good day.
It’s easier to be a parent this morning.
Character MATTERS.
Being a good person MATTERS.
This is a big deal.
It’s easy to do it the cheap way and get away with stuff — but it comes back around.
Today is a good day.
#PresidentBiden
#VotersDecided
Niloufar Keshmiri retweeted
If there's a 269-269 tie then maybe it's a simulation.
Just kidding. I think.
Niloufar Keshmiri retweeted
Just voted. Felt good. iwillvote.com
Niloufar Keshmiri retweeted
.@StarbucksCanada are you kidding me?! This new @BeyondMeat, Cheddar & Egg breakfast sandwich is unreal. #BeyondMornings #ad
Niloufar Keshmiri retweeted
Three unique tea lattes rich in flavour. One very difficult decision. (Or, you know, just try them all)
#DareToTea
Niloufar Keshmiri retweeted
Here’s the flavour you’ve been waiting for:
A full flavoured tea latte infused with black sesame and garnished with sesame brittle.
Introducing the Black Sesame Tea Latte.
#DareToTea
Niloufar Keshmiri retweeted
Find your perfect flavour: pretty in pink or dark and daring.
Experience a Blossoming Rose Tea Latte or Black Sesame Tea Latte today.
#DareToTea

























